Amyotrophic lateral sclerosis or Charcot’s disease is a neurodegenerative disease that results in progressive paralysis and subsequent death. Diagnosing it is difficult and no curative treatment exists to date, making these challenges for research. In a new study, Inserm researcher Caroline Rouaux and her team at the Strasbourg Biomedical Research Centre (Inserm-Université de Strasbourg), in collaboration with researchers from Ludwig Maximilian University in Munich, CNRS and Sorbonne Université, show that electroencephalography could become a diagnostic and prognostic tool for the disease. Thanks to this type of examination, the scientists were able to reveal an atypical brain wave profile that could prove to be specific to the disease.
Inserm Launches Its New Campaign Against Fake News in Health
Inserm has launched a new component of its general public campaign, On gagne tous les jours à s’intéresser à la santé [We always benefit from focusing on health]. The Institute has created a series of fake products promising miracle solutions, like those promoted on social media.